Literature DB >> 10766875

Mutations in calcium-binding epidermal growth factor modules render fibrillin-1 susceptible to proteolysis. A potential disease-causing mechanism in Marfan syndrome.

D P Reinhardt1, R N Ono, H Notbohm, P K Müller, H P Bächinger, L Y Sakai.   

Abstract

Most extracellular proteins consist of various modules with distinct functions. Mutations in one common type, the calcium-binding epidermal growth factor-like module (cbEGF), can lead to a variety of genetic disorders. Here, we describe as a model system structural and functional consequences of two typical mutations in cbEGF modules of fibrillin-1 (N548I, E1073K), resulting in the Marfan syndrome. Large (80-120 kDa) wild-type and mutated polypeptides were recombinantly expressed in mammalian cells. Both mutations did not alter synthesis and secretion of the polypeptides into the culture medium. Electron microscopy after rotary shadowing and comparison of circular dichroism spectra exhibited minor structural differences between the wild-type and mutated forms. The mutated polypeptides were significantly more susceptible to proteolytic degradation by a variety of proteases as compared with their wild-type counterparts. Most of the sensitive cleavage sites were mapped close to the mutations, indicating local structural changes within the mutated cbEGF modules. Other cleavage sites, however, were observed at distances beyond the domain containing the mutation, suggesting longer range structural effects within tandemly repeated cbEGF modules. We suggest that proteolytic degradation of mutated fibrillin-1 may play an important role in the pathogenesis of Marfan syndrome and related disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10766875     DOI: 10.1074/jbc.275.16.12339

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Variability in gene-based knowledge impacts variant classification: an analysis of FBN1 missense variants in ClinVar.

Authors:  Linnea M Baudhuin; Michelle L Kluge; Katrina E Kotzer; Susan A Lagerstedt
Journal:  Eur J Hum Genet       Date:  2019-06-21       Impact factor: 4.246

Review 2.  Marfan syndrome in the third Millennium.

Authors:  Gwenaëlle Collod-Béroud; Catherine Boileau
Journal:  Eur J Hum Genet       Date:  2002-11       Impact factor: 4.246

3.  In vivo studies of mutant fibrillin-1 microfibrils.

Authors:  Noe L Charbonneau; Eric J Carlson; Sara Tufa; Gerhard Sengle; Elise C Manalo; Valerie M Carlberg; Francesco Ramirez; Douglas R Keene; Lynn Y Sakai
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

Review 4.  The latent transforming growth factor beta binding protein (LTBP) family.

Authors:  R Oklü; R Hesketh
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 5.  The molecular genetics of Marfan syndrome and related disorders.

Authors:  P N Robinson; E Arteaga-Solis; C Baldock; G Collod-Béroud; P Booms; A De Paepe; H C Dietz; G Guo; P A Handford; D P Judge; C M Kielty; B Loeys; D M Milewicz; A Ney; F Ramirez; D P Reinhardt; K Tiedemann; P Whiteman; M Godfrey
Journal:  J Med Genet       Date:  2006-03-29       Impact factor: 6.318

6.  Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability.

Authors:  Gerhard Sengle; Robert N Ono; Takako Sasaki; Lynn Y Sakai
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

7.  Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.

Authors:  Daniel P Judge; Nancy J Biery; Douglas R Keene; Jessica Geubtner; Loretha Myers; David L Huso; Lynn Y Sakai; Harry C Dietz
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  A novel mutation in fibrillin-1 gene identified in a Chinese family with marfan syndrome.

Authors:  Dan-Li Liu; Juan-Hui Cao; Jie Yang; Fen He; Yun Wang; Ning Fan; Xu-Yang Liu
Journal:  Int J Clin Exp Med       Date:  2015-05-15

9.  Targeting of bone morphogenetic protein growth factor complexes to fibrillin.

Authors:  Gerhard Sengle; Noe L Charbonneau; Robert N Ono; Takako Sasaki; Jennifer Alvarez; Douglas R Keene; Hans Peter Bächinger; Lynn Y Sakai
Journal:  J Biol Chem       Date:  2008-03-13       Impact factor: 5.157

10.  Fibrillin-1 directly regulates osteoclast formation and function by a dual mechanism.

Authors:  Kerstin Tiedemann; Iris Boraschi-Diaz; Irina Rajakumar; Jasvir Kaur; Peter Roughley; Dieter P Reinhardt; Svetlana V Komarova
Journal:  J Cell Sci       Date:  2013-09-15       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.